Results 31 to 40 of about 2,327,467 (213)

Uric acid and cardiometabolic diseases [PDF]

Clinical Hypertension, 2020
AbstractHyperuricemia, which has been considered as a cause of gout and nephrolithiasis has recently been suggested to be associated with hypertension, coronary heart disease, heart failure, atrial fibrillation, insulin resistance, and nonalcoholic fatty liver disease.
Seung Jae Lee, Byeong Kil Oh, Ki-Chul Sung   +2 more
openaire   +3 more sources

NAFLD fibrosis score is correlated with PCSK9 and improves outcome prediction of PCSK9 in patients with chest pain: a cohort study

Lipids in Health and Disease, 2022
Background The risk of liver fibrosis in non-alcoholic fatty liver disease (NAFLD) can be easily evaluated by noninvasive scoring systems, of which the NAFLD fibrosis score (NFS) is the most commonly used.
Jia Peng, Ming-Ming Liu, Jing-Lu Jin, Ye-Xuan Cao, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Qian Dong, Jing Sun, Rui-Xia Xu, Jian-Jun Li   +10 more
doaj   +1 more source

Rationale and design of a randomized controlled trial: The effect of intensive lipid-lowering therapy with PCSK9 inhibitor on endothelial-coverage of stent strut after percutaneous coronary intervention (PCI) for patients with acute coronary syndrome (ACS): Optical coherence tomography (OCT) study (PIECES-OCT study)

Heliyon, 2023
Background: For the patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI), dual antiplatelet therapy (DAPT) for at least 1 year is recommended in the guidelines to minimize the risk of stent thrombosis ...
Zheng Yin, Zhi-Fan Li, Wen-Jia Zhang, Shuang Zhang, Yong-Gang Sui, Yan-Lu Xu, Hai-Tao Zhang, Xiao-Ning Liu, Hong Qiu, Jing-Lin Zhao, Jian-Jun Li, Ke-Fei Dou, Jie Qian, Yong-Jian Wu, Na-Qiong Wu   +14 more
doaj   +1 more source

Cardio-metabolic risk factors in polycystic ovary syndrome [PDF]

, 2020
Author's accepted version (postprint).This is an Accepted Manuscript of an article published by Nova Science Publishers in Cardiometabolic Diseases and Risk Factors in July 2020.Available online: https://novapublishers.com/shop/cardiometabolic-diseases-
Tehrani, Fahimeh Ramezani, Behboudi-Gandevani, Samira   +1 more
core  

Trends of Cardiometabolic Diseases and Risk Factors Reported in All Included Studies.

, 2023
Trends of Cardiometabolic Diseases and Risk Factors Reported in All Included Studies.
Anna Mertelsmann (14675229), John M. Changalucha (4458643), Fredrick Kalokola (14675232), Khanh Pham (9160575), Keith Mages (7040297), Justin R. Kingery (12265237), Humphrey D. Mazigo (10031872), Robert N. Peck (12213335), Jennifer A. Downs (7908380), Saidi Kapiga (247732), Hyasinta Jaka (4374235)   +10 more
core   +1 more source

HbA1c-based rather than fasting plasma glucose-based definitions of prediabetes identifies high-risk patients with angiographic coronary intermediate lesions: a prospective cohort study

Cardiovascular Diabetology, 2023
Background Prediabetes is common and associated with poor prognosis in patients with acute coronary syndrome and those undergoing revascularization. However, the impact of prediabetes on prognosis in patients with coronary intermediate lesions remains ...
Chenxi Song, Sheng Yuan, Kongyong Cui, Zhongxing Cai, Rui Zhang, Jining He, Zheng Qiao, Xiaohui Bian, Shaoyu Wu, Haoyu Wang, Boqun Shi, Zhangyu Lin, Rui Fu, Chunyue Wang, Qianqian Liu, Lei Jia, Qiuting Dong, Kefei Dou   +17 more
doaj   +1 more source

Maximising use of population data on cardiometabolic diseases [PDF]

, 2022
The worldwide burden of adult cardiometabolic diseases such as hypertension, diabetes, obesity, and dyslipidaemia continues its relentless increase.
David Guwatudde, Damasceno, Albertino, Justine I Davies, Jennifer Manne-Goehler, Flood, David, David Flood, Manne-Goehler, Jennifer, Davies, Justine I., Jaacks, Lindsay, Guwatudde, David, Albertino Damasceno, Davies, Justine I   +11 more
core   +1 more source

Histone Deacetylases and Cardiometabolic Diseases [PDF]

Arteriosclerosis, Thrombosis, and Vascular Biology, 2015
Cardiometabolic disease, emerging as a worldwide epidemic, is a combination of metabolic derangements leading to type 2 diabetes mellitus and cardiovascular disease. Genetic and environmental factors are linked through epigenetic mechanisms to the pathogenesis of cardiometabolic disease.
Kan Hui, Yiew, Tapan K, Chatterjee, David Y, Hui, Neal L, Weintraub   +3 more
openaire   +2 more sources

Amine oxidase copper-containing 3 (AOC3) inhibition: a potential novel target for the management of diabetic retinopathy

International Journal of Retina and Vitreous, 2021
Background Diabetic retinopathy (DR), a microvascular complication of diabetes, is the leading cause of visual impairment in people aged 20–65 years and can go undetected until vision is irreversibly lost.
David S. Boyer, Joerg F. Rippmann, Michael S. Ehrlich, Remko A. Bakker, Victor Chong, Quan Dong Nguyen   +5 more
doaj   +1 more source

In the heart of adipobiology: cardiometabolic disease

Biomedical Reviews, 2009
Published on 1 December 1994 issue of Nature, the Jeffrey Friedman's discovery "gave leptin in the beginning" of the endocrine saga of adipose tissue. Onwards, studies on this tissue have enjoyed an explosive growth that conceptualized a novel field of research, adipobiology.
Chaldakov GN, Fiore M, Tonchev AB, Rancic G, Hristova MG, Tuncel N, Kostov DD, Nikolova V, Bojanic V, Aloe L   +9 more
openaire   +2 more sources